Allspring Global Investments Holdings, LLC Sigilon Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$0.74 - $1.64 $4,297 - $9,523
-5,807 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$1.24 - $3.03 $1,303 - $3,184
-1,051 Reduced 15.33%
5,807 $8,000
Q4 2021

Jan 28, 2022
BUY
$2.58 - $6.13 $17,693 - $42,039
6,858 New
6,858 $18,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email